Your browser doesn't support javascript.
loading
Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development.
Zbar, Berton; Glenn, Gladys; Merino, Maria; Middelton, Lindsay; Peterson, James; Toro, Jorge; Coleman, Jonathan; Pinto, Peter; Schmidt, Laura S; Choyke, Peter; Linehan, W Marston.
Afiliação
  • Zbar B; Urologic Oncology Branch, National Cancer Institute, Bethesda, Maryland 20892-1107, USA. zbarb@ncifcrf.gov
J Urol ; 177(2): 461-5; discussion 465, 2007 Feb.
Article em En | MEDLINE | ID: mdl-17222609
ABSTRACT

PURPOSE:

Familial renal carcinoma is defined as families with 2 or more individuals with renal cell carcinoma without evidence of known hereditary renal carcinoma syndromes. To better characterize this familial cancer we reviewed renal carcinoma families evaluated at the National Cancer Institute between 1990 and 2004 to identify distinctive features of these families. We also determined the risk of renal carcinoma in first-degree relatives of affected family members. MATERIALS AND

METHODS:

We evaluated 141 at risk asymptomatic relatives of affected individuals from 50 families with 2 or more members with renal carcinoma. Histology slides of renal tumors from affected family members were reviewed. At risk members from renal carcinoma families were screened for occult renal neoplasms by renal ultrasound and computerized tomography. DNA from select families was tested for germline mutations of known renal carcinoma genes when clinically indicated and constitutional cytogenetic analysis was performed to search for germline chromosome alterations.

RESULTS:

Familial renal carcinoma families could be subdivided into subtypes based on tumor multiplicity and renal tumor histology. Of 141 at risk members of renal carcinoma families screened for occult renal tumors 2 were found to have occult renal tumors, which were identified as renal oncocytoma and a solid tumor that was not resected, respectively. No histologically confirmed occult renal carcinomas were detected in at risk family members. Several families previously classified as having familial renal carcinoma were found on further evaluation to have hereditary renal cancer syndromes.

CONCLUSIONS:

Familial renal carcinoma is a heterogeneous clinical and pathological entity. Familial renal carcinoma was subdivided into groups based on tumor multiplicity and tumor pathology. The empirical risk of histologically documented renal carcinoma in first-degree relatives who were members of familial renal carcinoma families was less than 1141. One renal oncocytoma and 1 small solid renal tumor were detected.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2007 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2007 Tipo de documento: Article